Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFusion Antibodies Regulatory News (FAB)

Share Price Information for Fusion Antibodies (FAB)

Share Price is delayed by 15 minutes
Get Live Data
12.75    -0.25 (-1.92%)
Bid:
12.00
Ask:
13.50
Spread: 1.50 (12.50%)
Market Cap: £15.94m
FAB Live PriceLast checked at - London Stock Exchange

Intraday Fusion Antibodies Share Chart

Acquisition

18 Jun 2007 07:01

Fabian Romania Property Fund Ltd18 June 2007 18 June 2007 Fabian Romania Property Fund Limited ("Fabian Romania" or "Fabian") Fabian Romania acquires the Baneasa Business Center in north Bucharest fromImmoconsult for €23.9 million Fabian Romania is pleased to announce that it has entered into an agreement topurchase its seventh office project in central north Bucharest from ImmoconsultLeasinggesellschaft m.b.H, with a transaction value of €23.9 million. Oncerefinanced, Fabian Romania's net equity investment will be €5 million. Theannual rental income is approximately €1.85 million per annum. Since itsAdmission to AIM, Fabian Romania has entered into four investments committingapproximately €34 million of the funds raised. The Baneasa Business Center provides 9,600 square metres of lettable space andis fully let. It is located in the central business district of north Bucharestand has a highly visible and prominent 32 metre frontage to Bucaresti-PloiestiSt, which runs directly north to the International airport. The immediatevicinity is well serviced by the main transport systems of Bucharest, and iswithin one of the fastest growing development locations of the city for bothoffice and retail estates. The Bucaresti-Ploiesti highway leads directly fromthe city center to Ploiesti City and links to the main E60 road to Brasov andTransylvania. The building offers good flexibility, having been constructed in three phases ina "Z" shape. Phase 1 of the building comprises a ground floor plus seven levels,whilst phases 2 and 3 both provide ground floor and nine upper levels, all werebuilt to Class A specification. Overground and underground parking facilitiesprovide for 132 vehicles. The Baneasa Business Center is currently fully let to fourteen internationaltenants, including Wrigley, Colgate, Fresenius, Cargill and Volksbank. There area variety of reversionary leases at rents between €12 per square metre to €16per square metre, providing an annual rental income of approximately €1.85million per annum. Concurrent with signing the acquisition Fabian has concluded debt financing withthe vendor's parent company Investkredit, via an 80 per cent. facility, reducingthe net equity requirement of Fabian Romania to approximately €5 million. Thisis the fourth credit facility Fabian has agreed with Investkredit in Romania. Claudius Ferentz, Managing Director of Investkredit Romania, quoted "This isanother exciting acquisition for Fabian and we are very pleased to have againpartnered them in providing an excellent financial services in a competitiveenvironment". Investkredit used the same team as per previous Fabian transactions, whichincluded Salans advising on legal aspects and NNKP representing Fabian. Responsible for the acquisition, Mark Owen, Property Director of Fabian Capital,Fabian Romania's investment adviser said: "This is further exciting news from Fabian, with three transactions announcedover the last three weeks. This acquisition adds an exciting asset managementopportunity to the Fabian Romania portfolio and has been converted from thepipeline discussed with investors at AIM admission. Over the medium term weshall aim to renegotiate the tenants' leases as they come up for renewal tocreate added value. The building is extremely flexible in design and is able toprovide floor plates between 700-1000sqm for which there is a shortage in themarket. Our ability to purchase a building of this type clearly sets us apartfrom our competitors and enables us to diversify in a fast moving emergingmarket". The lead advisers on the transaction were Eurisko (property agent), WSP(technical adviser), NNKP (legal adviser), KPMG (financial and tax adviser) andBiris Goran (legal advisor to Immoconsult) For Comments: Fabian Romania:Mark Holdsworth +44 20 7499 9988 Nominated Adviser:Deloitte & Touche LLPJames Lewis +44 20 7936 3000 Broker:Shore Capital Stockbrokers LimitedDru Danford +44 20 7408 4090 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
31st Jan 20257:00 amRNSOptiMAL R&D Update
4th Dec 202411:31 amRNSApproval of Grant Funding Application
19th Nov 20247:00 amRNSHalf-year Report
16th Oct 20241:23 pmRNSDirector/PDMR Shareholding
16th Oct 20247:00 amRNSIssue of shares to non-executive directors
8th Oct 202412:32 pmRNSResult of AGM
8th Oct 20247:00 amRNSAGM statement and trading update
2nd Oct 20247:00 amRNSBlock admission six monthly return
12th Sep 20249:54 amRNSNotice of AGM
9th Sep 202412:35 pmRNSDirector/PDMR Shareholding
5th Sep 202412:15 pmRNSDirector/PDMR Shareholding
5th Sep 20247:00 amRNSFinal Results
22nd Jul 202412:54 pmRNSDirector/PDMR Shareholding
4th Jul 20247:00 amRNSTrading update
23rd May 20247:00 amRNSNew contract with existing client
2nd May 20247:00 amRNSInvestor presentation
30th Apr 20247:00 amRNSYear-end trading statement
16th Apr 20247:00 amRNSChange of auditor
15th Apr 20247:00 amRNSContract to develop a bespoke OptiPhage library
2nd Apr 20242:34 pmRNSBlock admission six monthly return
28th Mar 20245:00 pmRNSTotal Voting Rights
11th Mar 20243:04 pmRNSHolding(s) in Company
11th Mar 20249:10 amRNSHolding(s) in Company
8th Mar 20243:09 pmRNSHolding(s) in Company
5th Mar 202410:40 amRNSResult of General Meeting and Total Voting Rights
29th Feb 20245:00 pmRNSTotal Voting Rights
27th Feb 20247:00 amRNSFirst purchase order under MSA
14th Feb 20247:15 amRNSGrant of options and issue of shares to directors
14th Feb 20247:00 amRNSPlacing to raise £1,375,000
6th Feb 20247:00 amRNSFollow-on project award and R&D update
1st Feb 20247:00 amRNSHMRC R&D tax credit
4th Dec 202312:26 pmRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSHalf-year Report
28th Nov 20237:00 amRNSOptiMAL collaboration agreement
9th Nov 20237:00 amRNSHalf year trading update
27th Oct 202311:57 amRNSResult of AGM
4th Oct 20232:45 pmRNSBlock admission six monthly return
29th Sep 20237:00 amRNSFinal Results
29th Aug 20237:00 amRNSUpdate on AI/ML-Ab service offering
24th Aug 20237:00 amRNSAppointment of interim CFO
21st Aug 20237:00 amRNSUpdate on AI/ML-Ab™ antibody discovery service
14th Aug 20237:00 amRNSUpdate on restructure and cost savings
30th Jun 20235:00 pmRNSTotal Voting Rights
16th Jun 202310:09 amRNSHolding(s) in Company
15th Jun 20239:45 amRNSHolding(s) in Company
13th Jun 20232:44 pmRNSHolding(s) in Company
12th Jun 20233:34 pmRNSHolding(s) in Company
12th Jun 202311:02 amRNSDirector/PDMR Shareholding
8th Jun 202310:39 amRNSResult of GM and total voting rights
31st May 20235:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.